Tag: drug safety

Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight In the realm of clinical trials, the detection and expedited reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) is paramount to ensuring participant safety and regulatory compliance. This article serves as a tutorial…

Read More “Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight” »

Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings In the highly regulated environment of clinical research, the accurate detection and expedited reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) are critical components of ensuring patient safety, maintaining…

Read More “Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings” »

Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations In the complex landscape of clinical trials, the detection and reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) are critical components that must align with regulatory frameworks such as…

Read More “Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations” »

Digital Tools and Automation to Streamline SUSAR Detection & Expedited Reporting Digital Tools and Automation to Streamline SUSAR Detection & Expedited Reporting In the landscape of clinical research, the identification and reporting of Serious Unexpected Suspected Adverse Reactions (SUSARs) is critical to ensuring participant safety and maintaining compliance with regulatory guidelines. This article provides a…

Read More “Digital Tools and Automation to Streamline SUSAR Detection & Expedited Reporting” »

SUSAR Detection & Expedited Reporting: End-to-End Compliance Framework for Global Clinical Trials SUSAR Detection & Expedited Reporting: End-to-End Compliance Framework for Global Clinical Trials Introduction to SUSAR in Clinical Trials Serious Unexpected Suspected Adverse Reactions (SUSARs) play a critical role in ensuring patient safety during clinical trials. The detection and expedited reporting of SUSARs are…

Read More “SUSAR Detection & Expedited Reporting: End-to-End Compliance Framework for Global Clinical Trials” »

SUSAR Detection & Expedited Reporting in Practice: Step-by-Step Guide for Sponsors and CROs SUSAR Detection & Expedited Reporting in Practice: Step-by-Step Guide for Sponsors and CROs Introduction to SUSARs in Clinical Trials Safety monitoring in clinical trials is paramount, especially when it involves vulnerable patient populations, such as those undergoing treatment for non-small cell lung…

Read More “SUSAR Detection & Expedited Reporting in Practice: Step-by-Step Guide for Sponsors and CROs” »